InvestorsHub Logo
Followers 6
Posts 584
Boards Moderated 0
Alias Born 02/12/2013

Re: None

Wednesday, 10/22/2014 12:57:58 PM

Wednesday, October 22, 2014 12:57:58 PM

Post# of 130502
Jason Napodano "The company is also developing an AD diagnostic test with early results showing sensitivity (correctly diagnosing AD) = 97% and specificity (correctly identifying individuals without AD) = 96%."

http://seekingalpha.com/article/2575735-neurotrope-tackles-alzheimers-disease-with-novel-mechanism